Fundraising FoxCantos Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)
BoardCraig Asher(Director)inJimmy Yun(Director)in
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesGaingelsHarpoon Ventures+10 more
__Twitter.png)
ResistanceBio develops treatments to address drug resistance in cancer patients.
BiotechHealthtechSan Francisco, US
Nicholas Goldner(CEO)inChristopher Bulow(Founder)inKYLE LAPHAM(Executive Officer, Director)
BoardOMRI AMIRAV-DRORY(Director)in
Co-investorsAlumni VenturesFifty YearsY CombinatorAsymmetry VenturesBrightstone Venture CapitalCentennial Investors+11 more
Salient Motion designs and manufactures critical actuation systems for commercial aviation and defense applications.
Advanced ManufacturingDefense TechHardwareSouthern California, US
Vishaal Mali(Founder)inAidan Jenkins(Founder)Tristan Fauntleroy(Founder)
Co-investorsBoeing HorizonX VenturesBoxGroupDns CapitalHummingbird VenturesIn-Q-TelMana Ventures+2 more
Shinkei deploys robotics and computer vision hardware on commercial fishing vessels to process seafood at sea, improving quality and traceability while reducing America's seafood import reliance.
Advanced ManufacturingAgTechAI & Machine LearningFoodTechHardwareRoboticsLos Angeles, US
Saif Khawaja(Founder)inReed Ginsberg(Vice President, Engineering)Grant Gregory(Investor)Imani Moody(Operations)Zhifei Shen(Engineering)Adam Edelhauser(Engineering)
Co-investorsDorm RoomGlobal BrainHumba VenturesImpatient VenturesLontra VenturesMantis Capital+18 more
.jpeg){kind=logo}
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.